Selpercatinib 40mg Capsules – 120 Count

Verified Supplier CHP00231

Available in
Hong Kong
Supplier based in
Hong Kong
  • All products listed on Conect2health are verified and approved to help ensure a reliable purchasing experience.
  • Conect2health assists you in connecting with suppliers for product enquiries and purchasing requirements.
  • Need help with a supplier, product information, or any other related query? Our team is here to support you throughout the process.
Seller Avatar
Hong Kong Dengyue Pharmaceutical Limited
Verified · Response time ≤ 5h · Hong Kong
View profile →

Product Description

Selpercatinib 40mg is a prescription oral capsule formulated as a selective RET (rearranged during transfection) kinase inhibitor, indicated for use in adult and pediatric patients with certain RET-altered cancers, including RET fusion-positive non-small cell lung cancer, RET-mutant medullary thyroid cancer, and RET fusion-positive thyroid cancer, as determined by an FDA-approved test. Each capsule contains 40 mg of selpercatinib for oral administration. Each bottle contains 120 capsules. Storage: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F to 86°F). Store in the original container, tightly closed, and keep out of reach of children. Dispensing status: Rx Only — available exclusively with a valid prescription.

Shipping & Packaging

Lead time
N/A
Payment terms
N/A
Port of loading
N/A
Target Regions
Hong Kong

Similar Products